The Effect of Chitosan Supplementation on the Gut Microbiota and Various Health Factors in Icelandic Females: A Placebo‐Controlled, Double‐Blind, Randomized Trial
Molecular Nutrition & Food Research · 2025
DOI: 10.1002/mnfr.70137 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Molecular Nutrition & Food Research, 2025. Verfasst von Thelma Rún Rúnarsdóttir und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Food Science and Nutrition, School of Health Sciences, University of Iceland, Reykjavik. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Chitosan, Dietary Supplements. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Technology Development Fund in Iceland.
Abstract (Originalsprache)
Chitosan is suggested to have prebiotic properties, yet clinical evidence on its in vivo effects on the human gut microbiota and various health factors remains scarce. This study aimed to evaluate the effects of chitosan supplementation on gut microbiota composition and various health factors in Icelandic females. Sixty Icelandic females (aged 26–70; BMI 19.1–35.0 kg/m 2 ) were randomized to a 12‐week intervention receiving either 3 g/day of encapsulated chitosan (LipoSan Ultra) (TRG, n = 28) or placebo (PLG, n = 32). Anthropometrics, health factors, endurance, and health status questionnaires were collected at baseline (T1) and post‐intervention (T3). All values remained within reference ranges at both timepoints in both groups, except weight, waist circumference, and fat mass, which were above. In TRG, alkaline phosphatase (ALP) levels increased, and fecal consistency shifted toward constipation. 16S rRNA microbial analysis showed decreased diversity/evenness, increased T1–T3 separation by nonmetric multidimensional scaling, and higher Actinobacteriota abundance. Genus level shifts included reduced Blautia, Eubacterium hallii , CAG‐56 levels and increased Ruminococcus gnavus, Clostridium innocuum, Bifidobacterium , and Holdemania . This novel clinical study demonstrates that 12 weeks of chitosan supplementation alters gut microbiota composition without affecting general health status in females. Trial Registration This trial was registered at Clinicaltrials.gov as NCT04551365
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Food Science and Nutrition, School of Health Sciences, University of Iceland, Reykjavik.
- Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik.
- Reykjalundur Rehabilitation Center, Mosfellsbær, Iceland.
- Matis ohf., Reykjavik, Iceland.
ORCID-Profile: Thelma Rún Rúnarsdóttir
Förderung
- Technology Development Fund in Iceland
Zitieren
APA
Rúnarsdóttir, T. R., Skírnisdóttir, S., Thors, H., Harðardóttir, H., Corral-Jara, K. F., Klonowski, A. M., Halldórsson, Þ. I., Marteinsson, V. Þ., & Guðjónsdóttir, M. (2025). The Effect of Chitosan Supplementation on the Gut Microbiota and Various Health Factors in Icelandic Females: A Placebo‐Controlled, Double‐Blind, Randomized Trial. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.70137
Vancouver
Rúnarsdóttir TR, Skírnisdóttir S, Thors H, Harðardóttir H, Corral-Jara KF, Klonowski AM, et al. The Effect of Chitosan Supplementation on the Gut Microbiota and Various Health Factors in Icelandic Females: A Placebo‐Controlled, Double‐Blind, Randomized Trial. Molecular Nutrition & Food Research. 2025. doi:10.1002/mnfr.70137
BibTeX
@article{Rnarsdttir2025,
author = {Rúnarsdóttir, Thelma Rún and Skírnisdóttir, Sigurlaug and Thors, Hildur and Harðardóttir, Hjördís and Corral-Jara, Karla F and Klonowski, Alexandra M and Halldórsson, Þórhallur Ingi and Marteinsson, Viggó Þór and Guðjónsdóttir, Marta},
title = {The Effect of Chitosan Supplementation on the Gut Microbiota and Various Health Factors in Icelandic Females: A Placebo‐Controlled, Double‐Blind, Randomized Trial},
journal = {Molecular Nutrition & Food Research},
year = {2025},
doi = {10.1002/mnfr.70137}
}
EUVIMED